MTOR and Alzheimer disease: Given the correlation between T14 and p-mTOR in human midbrain samples from AD patients [10], as well as their involvement in the inhibition of autophagy and neurodegeneration, the cyclic variant NBP14 could potentially be used to reverse these effects.